KEGG   DRUG: Danburstotug
Entry
D12349                      Drug                                   
Name
Danburstotug (USAN)
Formula
C6380H9914N1692O1997S42
Exact mass
143529.4501
Mol weight
143617.93
Sequence
(Heavy chain)
QMQLVQSGAE VKKPGSSVKV SCKASGGTFS SYAYSWVRQA PGQGLEWMGG IIPSFGTANY
AQKFQGRVTI TADESTSTAY MELSSLRSED TAVYYCARGP IVATITPLDY WGQGTLVTVS
SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD
ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
WQQGNVFSCS VMHEALHNHY TQKSLSLSPG K
(Light chain)
SYVLTQPPSV SVAPGKTATI ACGGENIGRK TVHWYQQKPG QAPVLVIYYD SDRPSGIPER
FSGSNSGNTA TLTISRVEAG DEADYYCLVW DSSSDHRIFG GGTKLTVLGQ PKAAPSVTLF
PPSSEELQAN KATLVCLISD FYPGAVTVAW KADSSPVKAG VETTTPSKQS NNKYAASSYL
SLTPEQWKSH RSYSCQVTHE GSTVEKTVAP TECS
(Disulfide bridge: H22-H96, H148-H204, H224-L213, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'96, H'148-H'204, H'224-L'213, H'265-H'325, H'371-H'429, L22-L87, L136-L195, L'22-'87, L'136-L'195)
  Type
Peptide
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Efficacy
Antineoplastic, Immune checkpoint inhibitor, Anti-PD-L1 antibody
  Type
Monoclonal antibody
Target
PDL1 (CD274) [HSA:29126] [KO:K06745]
  Pathway
hsa04514  Cell adhesion molecules
hsa05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D12349  Danburstotug
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    PDL1 (CD274)
     D12349  Danburstotug (USAN)
Other DBs
CAS: 2307144-65-4
PubChem: 497620762
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system